NRC Health (NRC) stock
NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/3078% above fair value
$26.16+0.27 (+1.06%)
Close on Nov 18, 2026Market cap $578.65MP/E –Yield 1.99%
NRC Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
NRC Health's revenue for the twelve months ending Jun 30, 2026 was $140.00M, down 0.2% year over year. For fiscal 2025 it was $137.39M, down 4.0% from the year before. Over ten years it grew 3.0% a year on average. The highest annual figure on record is $151.57M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $137.39M | -4.0% |
| FY2024 | Dec 31, 2024 | $143.06M | -3.7% |
| FY2023 | Dec 31, 2023 | $148.58M | -2.0% |
| FY2022 | Dec 31, 2022 | $151.57M | +2.4% |
| FY2021 | Dec 31, 2021 | $147.95M | +11.0% |
| FY2020 | Dec 31, 2020 | $133.28M | +4.1% |
| FY2019 | Dec 31, 2019 | $127.98M | +6.9% |
| FY2018 | Dec 31, 2018 | $119.69M | +1.8% |
| FY2017 | Dec 31, 2017 | $117.56M | +7.5% |
| FY2016 | Dec 31, 2016 | $109.38M | +6.9% |
| FY2015 | Dec 31, 2015 | $102.34M | +3.5% |
| FY2014 | Dec 31, 2014 | $98.84M | +6.7% |
| FY2013 | Dec 31, 2013 | $92.59M | +7.1% |
| FY2012 | Dec 31, 2012 | $86.42M | +14.1% |
| FY2011 | Dec 31, 2011 | $75.77M | +19.5% |
| FY2010 | Dec 31, 2010 | $63.40M | +9.9% |
| FY2009 | Dec 31, 2009 | $57.69M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $35.39M | +4.0% |
| Q1 FY2026 | Mar 31, 2026 | $34.80M | +3.7% |
| Q4 FY2025 | Dec 31, 2025 | $35.19M | -4.6% |
| Q3 FY2025 | Sep 30, 2025 | $34.61M | -3.4% |
| Q2 FY2025 | Jun 30, 2025 | $34.04M | -2.8% |
| Q1 FY2025 | Mar 31, 2025 | $33.55M | -5.0% |
| Q4 FY2024 | Dec 31, 2024 | $36.91M | -2.9% |
| Q3 FY2024 | Sep 30, 2024 | $35.82M | -5.6% |
| Q2 FY2024 | Jun 30, 2024 | $35.02M | -3.2% |
| Q1 FY2024 | Mar 31, 2024 | $35.31M | -3.2% |
| Q4 FY2023 | Dec 31, 2023 | $38.00M | -0.4% |
| Q3 FY2023 | Sep 30, 2023 | $37.95M | +0.7% |
| Q2 FY2023 | Jun 30, 2023 | $36.16M | -3.0% |
| Q1 FY2023 | Mar 31, 2023 | $36.47M | -5.1% |
| Q4 FY2022 | Dec 31, 2022 | $38.14M | -0.4% |
| Q3 FY2022 | Sep 30, 2022 | $37.69M | -0.2% |
| Q2 FY2022 | Jun 30, 2022 | $37.29M | +2.4% |
| Q1 FY2022 | Mar 31, 2022 | $38.44M | +8.4% |
| Q4 FY2021 | Dec 31, 2021 | $38.30M | +10.1% |
| Q3 FY2021 | Sep 30, 2021 | $37.77M | +12.8% |
| Q2 FY2021 | Jun 30, 2021 | $36.43M | +16.9% |
| Q1 FY2021 | Mar 31, 2021 | $35.46M | +4.7% |
| Q4 FY2020 | Dec 31, 2020 | $34.77M | +6.6% |
| Q3 FY2020 | Sep 30, 2020 | $33.48M | +3.1% |
| Q2 FY2020 | Jun 30, 2020 | $31.17M | -0.8% |
| Q1 FY2020 | Mar 31, 2020 | $33.86M | +7.6% |
| Q4 FY2019 | Dec 31, 2019 | $32.62M | +6.5% |
| Q3 FY2019 | Sep 30, 2019 | $32.47M | +8.2% |
| Q2 FY2019 | Jun 30, 2019 | $31.41M | +12.1% |
| Q1 FY2019 | Mar 31, 2019 | $31.48M | +1.5% |
| Q4 FY2018 | Dec 31, 2018 | $30.64M | +2.5% |
| Q3 FY2018 | Sep 30, 2018 | $30.01M | +3.7% |
| Q2 FY2018 | Jun 30, 2018 | $28.02M | -1.5% |
| Q1 FY2018 | Mar 31, 2018 | $31.02M | +2.4% |
| Q4 FY2017 | Dec 31, 2017 | $29.90M | +5.4% |
| Q3 FY2017 | Sep 30, 2017 | $28.95M | +7.1% |
| Q2 FY2017 | Jun 30, 2017 | $28.44M | – |
| Q1 FY2017 | Mar 31, 2017 | $30.28M | – |
| Q4 FY2016 | Dec 31, 2016 | $28.37M | – |
| Q3 FY2016 | Sep 30, 2016 | $27.03M | – |
See a number that looks wrong?